Is DiaSorin (BIT:DIA) Using Too Much Debt?
Mar 16
Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Healthcare Sector Analysis
UpdatedMar 17, 2025
DataAggregated Company Financials
Companies16
- 7D-3.4%
- 3M-5.3%
- 1Y-11.2%
- YTD-6.1%
The Healthcare industry is down 3.4% over the last week with Amplifon the worst performer, down 6.2%. However, the industry is down 11% over the past year. As for the next few years, earnings are expected to grow by 11% per annum.
Sector Valuation and Performance
Has the Italian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 18 Mar 2025 | €22.9b | €19.6b | €796.0m | 21.2x | 28.8x | 1.2x |
| Thu, 13 Feb 2025 | €26.0b | €20.0b | €828.0m | 23.6x | 31.4x | 1.3x |
| Sat, 11 Jan 2025 | €24.9b | €8.0b | €834.7m | 22.1x | 29.8x | 3.1x |
| Mon, 09 Dec 2024 | €24.6b | €19.0b | €1.4b | 19.2x | 17.2x | 1.3x |
| Wed, 06 Nov 2024 | €24.7b | €18.9b | €1.4b | 16.1x | 18x | 1.3x |
| Fri, 04 Oct 2024 | €24.4b | €18.9b | €1.4b | 17.2x | 17.7x | 1.3x |
| Sun, 01 Sep 2024 | €26.1b | €18.9b | €1.4b | 15.4x | 18.8x | 1.4x |
| Tue, 30 Jul 2024 | €26.0b | €18.8b | €1.4b | 17.1x | 18.8x | 1.4x |
| Thu, 27 Jun 2024 | €25.8b | €18.8b | €1.4b | 16x | 18.6x | 1.4x |
| Sat, 25 May 2024 | €26.0b | €18.8b | €1.4b | 17.2x | 18.8x | 1.4x |
| Mon, 22 Apr 2024 | €25.3b | €18.7b | €1.4b | 19.3x | 18.4x | 1.4x |
| Wed, 20 Mar 2024 | €25.7b | €18.6b | €1.4b | 20.4x | 18.4x | 1.4x |
| Fri, 16 Feb 2024 | €25.0b | €18.6b | €1.4b | 18.7x | 18x | 1.3x |
| Sun, 14 Jan 2024 | €25.3b | €18.6b | €1.4b | 18.1x | 18.2x | 1.4x |
| Tue, 12 Dec 2023 | €23.6b | €18.6b | €1.4b | 18.3x | 16.9x | 1.3x |
| Thu, 09 Nov 2023 | €22.7b | €18.6b | €1.4b | 17x | 16.2x | 1.2x |
| Sat, 07 Oct 2023 | €22.7b | €18.6b | €1.4b | 16.5x | 15.7x | 1.2x |
| Mon, 04 Sep 2023 | €23.8b | €17.3b | €1.1b | 16x | 20.9x | 1.4x |
| Wed, 02 Aug 2023 | €24.0b | €7.8b | €857.4m | 15.3x | 28x | 3.1x |
| Fri, 30 Jun 2023 | €23.9b | €7.7b | €822.5m | 17.5x | 29.1x | 3.1x |
| Sun, 28 May 2023 | €24.2b | €7.7b | €822.5m | 22.6x | 29.4x | 3.1x |
| Tue, 25 Apr 2023 | €24.0b | €7.6b | €826.9m | 21.2x | 29x | 3.2x |
| Thu, 23 Mar 2023 | €22.8b | €7.6b | €868.1m | 19x | 26.3x | 3x |
| Sat, 18 Feb 2023 | €23.9b | €7.4b | €886.1m | 24.7x | 27x | 3.2x |
| Mon, 16 Jan 2023 | €24.0b | €7.4b | €886.1m | 23.9x | 27.1x | 3.2x |
| Wed, 14 Dec 2022 | €25.0b | €7.4b | €886.1m | 22.7x | 28.2x | 3.4x |
| Fri, 11 Nov 2022 | €24.8b | €7.3b | €895.7m | 21.3x | 27.7x | 3.4x |
| Sun, 09 Oct 2022 | €21.8b | €7.3b | €908.8m | 20.1x | 24x | 3x |
| Tue, 06 Sep 2022 | €23.9b | €7.2b | €886.8m | 22x | 26.9x | 3.3x |
| Thu, 04 Aug 2022 | €26.2b | €7.1b | €900.9m | 23.1x | 29.1x | 3.7x |
| Sat, 02 Jul 2022 | €25.2b | €6.9b | €957.4m | 21.2x | 26.3x | 3.7x |
| Mon, 30 May 2022 | €26.0b | €7.0b | €966.7m | 21.8x | 26.9x | 3.7x |
| Wed, 27 Apr 2022 | €27.7b | €6.8b | €952.4m | 23.3x | 29.1x | 4.1x |
| Fri, 25 Mar 2022 | €28.2b | €6.7b | €951.9m | 22.9x | 29.6x | 4.2x |
Price to Earnings Ratio
29.6x
Current Industry PE
- Investors are optimistic on the Italian Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 28.8x which is higher than its 3-year average PE of 23.5x.
- The 3-year average PS ratio of 2.3x is higher than the industry's current PS ratio of 1.2x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 8.2% per year over the last three years.
- Meanwhile revenues for these companies have grown 40% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Italian Healthcare sector?
| IT Market | 1.36% | |
| Healthcare | -3.40% | |
| Biotech | 1.97% | |
| Life Sciences | -1.21% | |
| Pharma | -1.59% | |
| Healthtech | -3.80% | |
| Healthcare Services | -3.80% | |
| Medical Equipment | -6.88% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 36.3x.
- Analysts are expecting annual earnings growth of 18.5%, which is higher than its past year's earnings decline of 1.0% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 43% over the next 5 years.
- However this is lower than its past earnings growth rate of 280% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 75% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PHIL Philogen | €18.95 | 2.4% +€18.1m | 6.5% | PS194.8x | |
| GHC Garofalo Health Care | €4.97 | 0.4% +€1.8m | 3.8% | PE20.3x | |
| HI Health Italia | €119.00 | 7.7% +€1.6m | -4.8% | PE13.2x | |
| IVN iVision Tech | €2.34 | 9.3% +€1.6m | 196.2% | PS0.002x | |
| UBM Ulisse Biomed | €0.79 | 1.3% +€244.8k | -44.5% | PS45.8x |